An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF - Contacts and Locations

Home

An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF

This study has been terminated.
Information provided by InterMune

Please refer to this study by its ClinicalTrials.gov identifier: NCT00076635

Locations


United States, California
	Intermune Inc
	Brisbane, California, United States, 94005

Sponsors and Collaborators

InterMune

Investigators


Investigator:	InterMune, Inc. 888-486-6411	Medical Information